Search

You searched for "learning"

1158 results found

Medical Aesthetic Injectable Summit (MAIS)

4 October 2024 -5 October 2024
The Medical Aesthetic Injectable Summit (MAIS)From Thinkin by Dr. Benjamin Ascher Welcome to the inaugural Injectable Summit 2024 (MAIS 2024), a gathering that’s never happened in our profession before! This summit is dedicated to all leaders in the medical aesthetic...

MD/PhDs or MD/MBAs: which do we need more to innovate in plastic surgery?

1 February 2014 | | PMFA - General Plastic Surgery
I would like to thank Arlen Meyers and Victor Castro for submitting this article. One of the problems that I have seen in my professional lifetime is the failure of entrepreneurs to grasp that there is no infinite health care...

RSM Aesthetics

6 September 2024 -7 September 2024
RSM Aesthetics will be held at the Royal Society of Medicine in London on 6 and 7 September 2024. The event comprises a day of advanced talks and a day of hands-on masterclass workshops where doctors, dentists and surgeons will...

Cheek and lip reconstruction

10 February 2014 | | PMFA - Facial Plastic Surgery
The authors present a well-structured review of the reconstruction of cutaneous defects of the cheek and lip. They present new findings that have an impact on the planning and understanding of local flaps for the reconstruction of both areas. Integrated...

Do the benefits of scaphoidectomy and four-corner fusion for SLAC last?

1 October 2013 | | PMFA - Hand & Wrist Surgery
The paper concisely covers the history and definition of scapholunate advanced collapse (SLAC) wrist. The treatments options are described in broad terms and referenced. Forty patients’ records are assessed retrospectively; their data having been collected prospectively in a structured and...

The new era of advanced AI-powered aesthetics

4 December 2024 | | PMFA - Aesthetic Medicine
“AI is the most powerful technology force of our time.” Jensen Huang, Nvidia CEO. The 101 on AI Artificial intelligence (AI) is set to redefine our social, economic and healthcare infrastructure. Artificial intelligence represents machine learning designed to be intuitive...

MAX (Merz Aesthetics Exchange®) launches in the UK & Ireland

8 January 2025 | Research & Development, Company Profiles
Merz Aesthetics® UK & Ireland announces the launch of a new comprehensive educational ecosystem – MAX, Merz Aesthetics Exchange. For UK & Irish healthcare professionals only.

OPINION - Influencers affect us all: but are they as good as we think?

16 May 2022 | | PMFA - General Plastic Surgery
Recently I was approached by the son of a 75-year-old lady for a second opinion on a large fungating malignant melanoma on the outer lateral aspect of her left thigh. She had noticed an enlarging 50p size pigmented lesion just...

Hydroquinone-induced hyperpigmentation: a case of exogenous ochronosis in a Hispanic patient

17 November 2020 | | PMFA - Aesthetic Medicine, PMFA - Dermatology, PMFA - Facial Plastic Surgery
Achieving flawless skin as part of the desire to be perceived as ‘beautiful’ is a common sentiment shared by many cultures [1]. Of the many treatment options and products available on the market, the most common chemical agent to achieve...

How I Do It - NSR with dermal fillers

1 February 2022 | | PMFA - Aesthetic Medicine, PMFA - Rhinoplasty, PMFA - Facial Plastic Surgery
Year on year non-surgical rhinoplasty (NSR) has become increasingly popular and after first learning the technique with a needle, I was taught the cannula technique. Currently, I practise both techniques regularly and often use threads on bulky noses. Indications The...

In conversation with Professor Peter Adamson

1 August 2018 | | PMFA - Facial Plastic Surgery, PMFA - General Plastic Surgery, PMFA - Maxillofacial Surgery
We were delighted to catch up with Peter A Adamson, Professor of the Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology - Head and Neck Surgery, University of Toronto. Professor Peter A Adamson. Can you tell us a...

Recurrent corneal erosions secondary to isotretinoin use

4 March 2021 | | PMFA - Dermatology
This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...